On August 26, 2010, the Board of BioPorto A/S decided to take out convertible
loans of the total nominal value of minimum DKK 7 million and maximum DKK 20
million through a private placement, as published in announcement no. 09 of
August 26, 2010.
A total amount of DKK 13.95 million of convertible bonds has been subscribed
and the loan is fully paid. The Board has decided to issue bonds for the full
subscription amount. Issuance of the convertible bonds will take place on
September 08, 2010. The issue gives BioPorto gross proceeds of DKK 13.95
million, of which transaction costs will be deducted as well as expected costs
of prospectus preparation, totalling DKK 1.3 million. Net proceeds constitute
12.65 million. The prospectus preparation takes place as the bonds are put in
for admittance to trading on NASDAQ OMX Copenhagen in the fourth quarter of
2010.
Terms of the convertible bonds and the conversion right are set out in
announcement no. 09 of August 26, 2010. The Company's articles of association
are amended in accordance with the inclusion of the bond loan.
Distribution of the convertible bonds:
The issuance of the convertible bonds is distributed as follows:
Investors DKK million
Institutional investors 7.05
Private investors 5.10
BioPorto management 1.80
The company's board and management have signed convertible bonds for a total of
DKK 1.8 million corresponding to 12.9% of the bond loan, which is distributed
as follows:
Name Function DKK
Carsten Lønfeldt Chairman of the Board 300,000
Marianne Weile Board member 300,000
Peter Nordkild Board member 300,000
Niels Tækker Foged Board member 300,000
Thea Olesen CEO 300,000
Frank Harder CFO 300,000
Further information:
Thea Olesen, CEO
Christina Tønnesen, Investor Relations
Tel. +45 45 29 00 00, e-mail investor@bioporto.com
